Dermatology & Immunology
Atopic Dermatitis Clinical Research
Atopic dermatitis (eczema) is a chronic inflammatory skin condition that affects millions of children, adolescents, and adults worldwide. CenExel partners with sponsors to advance innovative dermatology treatments through specialized clinical research, diverse patient recruitment, and experienced investigative teams.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Atopic Dermatitis Research Through Specialized Clinical Trials
CenExel provides comprehensive support for atopic dermatitis and inflammatory skin disease studies, combining scientific expertise, operational excellence, and patient-focused care. Our experienced dermatology research teams help accelerate clinical development from early-phase studies through late-stage trials.
Conditions Covered
Dermatology Conditions We Research
Our dermatology research sites support a broad range of inflammatory and immune-mediated skin disorders.
- Atopic Dermatitis (Eczema)
- Chronic Pruritus
- Contact Dermatitis
- Pediatric Eczema
- Psoriasis
- Seborrheic Dermatitis
- Hand Eczema
- Prurigo Nodularis
Our Approach
Why Sponsors Choose CenExel for Dermatology Research
CenExel’s dermatology research expertise helps sponsors improve enrollment, operational efficiency, and patient engagement across clinical trials.
01
Experienced Dermatology Investigators
Our physician network includes experienced dermatology specialists with expertise in inflammatory skin disorders.
02
Strong Patient Recruitment
We use targeted outreach and digital recruitment strategies to support rapid enrollment.
03
Diverse Patient Populations
Access to broad demographic populations helps ensure inclusive dermatology research participation.
04
High Quality Trial Execution
Our operational teams focus on compliance, retention, and efficient study management.
Phase Coverage
Supported Dermatology Trial Phases
CenExel supports early and late-phase dermatology clinical research — from first-in-human studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our dermatology sites support biologics, topical therapies, immunology treatments, and innovative eczema therapies through experienced clinical operations and patient-centric care.
Dermatology Task Force
CenExel supports dermatology-focused clinical trials with experienced investigators, advanced recruitment capabilities, and access to diverse patient populations across multiple research sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
